145 related articles for article (PubMed ID: 18710207)
1. Structure-activity relationship study on anti-HIV 6-desfluoroquinolones.
Tabarrini O; Massari S; Daelemans D; Stevens M; Manfroni G; Sabatini S; Balzarini J; Cecchetti V; Pannecouque C; Fravolini A
J Med Chem; 2008 Sep; 51(17):5454-8. PubMed ID: 18710207
[TBL] [Abstract][Full Text] [Related]
2. Studies of anti-HIV transcription inhibitor quinolones: identification of potent N1-vinyl derivatives.
Tabarrini O; Massari S; Daelemans D; Meschini F; Manfroni G; Bottega L; Gatto B; Palumbo M; Pannecouque C; Cecchetti V
ChemMedChem; 2010 Nov; 5(11):1880-92. PubMed ID: 20928882
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, and biological evaluation of novel quinoline derivatives as HIV-1 Tat-TAR interaction inhibitors.
Chen S; Chen R; He M; Pang R; Tan Z; Yang M
Bioorg Med Chem; 2009 Mar; 17(5):1948-56. PubMed ID: 19217787
[TBL] [Abstract][Full Text] [Related]
4. Structure modifications of 6-aminoquinolones with potent anti-HIV activity.
Tabarrini O; Stevens M; Cecchetti V; Sabatini S; Dell'Uomo M; Manfroni G; Palumbo M; Pannecouque C; De Clercq E; Fravolini A
J Med Chem; 2004 Oct; 47(22):5567-78. PubMed ID: 15481992
[TBL] [Abstract][Full Text] [Related]
5. Structural investigation of the naphthyridone scaffold: identification of a 1,6-naphthyridone derivative with potent and selective anti-HIV activity.
Tabarrini O; Massari S; Sancineto L; Daelemans D; Sabatini S; Manfroni G; Cecchetti V; Pannecouque C
ChemMedChem; 2011 Jul; 6(7):1249-57. PubMed ID: 21567967
[TBL] [Abstract][Full Text] [Related]
6. 6-desfluoroquinolones as HIV-1 Tat-mediated transcription inhibitors.
Tabarrini O; Massari S; Cecchetti V
Future Med Chem; 2010 Jul; 2(7):1161-80. PubMed ID: 21426162
[TBL] [Abstract][Full Text] [Related]
7. 2-Phenylquinolones as inhibitors of the HIV-1 Tat-TAR interaction.
Gatto B; Tabarrini O; Massari S; Giaretta G; Sabatini S; Del Vecchio C; Parolin C; Fravolini A; Palumbo M; Cecchetti V
ChemMedChem; 2009 Jun; 4(6):935-8. PubMed ID: 19283692
[TBL] [Abstract][Full Text] [Related]
8. Structural modifications of quinolone-3-carboxylic acids with anti-HIV activity.
He QQ; Gu SX; Liu J; Wu HQ; Zhang X; Yang LM; Zheng YT; Chen FE
Bioorg Med Chem; 2011 Aug; 19(16):5039-45. PubMed ID: 21763149
[TBL] [Abstract][Full Text] [Related]
9. New HIV-1 replication inhibitors of the styryquinoline class bearing aroyl/acyl groups at the C-7 position: synthesis and biological activity.
Normand-Bayle M; Bénard C; Zouhiri F; Mouscadet JF; Leh H; Thomas CM; Mbemba G; Desmaële D; d'Angelo J
Bioorg Med Chem Lett; 2005 Sep; 15(18):4019-22. PubMed ID: 16002283
[TBL] [Abstract][Full Text] [Related]
10. Substituted tetrahydroquinolines as potent allosteric inhibitors of reverse transcriptase and its key mutants.
Su DS; Lim JJ; Tinney E; Wan BL; Young MB; Anderson KD; Rudd D; Munshi V; Bahnck C; Felock PJ; Lu M; Lai MT; Touch S; Moyer G; Distefano DJ; Flynn JA; Liang Y; Sanchez R; Prasad S; Yan Y; Perlow-Poehnelt R; Torrent M; Miller M; Vacca JP; Williams TM; Anthony NJ
Bioorg Med Chem Lett; 2009 Sep; 19(17):5119-23. PubMed ID: 19631528
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and anti-HIV activity of alkylated quinoline 2,4-diols.
Ahmed N; Brahmbhatt KG; Sabde S; Mitra D; Singh IP; Bhutani KK
Bioorg Med Chem; 2010 Apr; 18(8):2872-9. PubMed ID: 20350812
[TBL] [Abstract][Full Text] [Related]
12. Novel in vivo model for the study of human immunodeficiency virus type 1 transcription inhibitors: evaluation of new 6-desfluoroquinolone derivatives.
Stevens M; Pollicita M; Pannecouque C; Verbeken E; Tabarrini O; Cecchetti V; Aquaro S; Perno CF; Fravolini A; De Clercq E; Schols D; Balzarini J
Antimicrob Agents Chemother; 2007 Apr; 51(4):1407-13. PubMed ID: 17242146
[TBL] [Abstract][Full Text] [Related]
13. Exploiting the anti-HIV 6-desfluoroquinolones to design multiple ligands.
Sancineto L; Iraci N; Barreca ML; Massari S; Manfroni G; Corazza G; Cecchetti V; Marcello A; Daelemans D; Pannecouque C; Tabarrini O
Bioorg Med Chem; 2014 Sep; 22(17):4658-66. PubMed ID: 25127466
[TBL] [Abstract][Full Text] [Related]
14. Studies on anti-HIV quinolones: new insights on the C-6 position.
Massari S; Daelemans D; Manfroni G; Sabatini S; Tabarrini O; Pannecouque C; Cecchetti V
Bioorg Med Chem; 2009 Jan; 17(2):667-74. PubMed ID: 19091580
[TBL] [Abstract][Full Text] [Related]
15. Novel piperidinylpyrimidine derivatives as inhibitors of HIV-1 LTR activation.
Fujiwara N; Nakajima T; Ueda Y; Fujita H; Kawakami H
Bioorg Med Chem; 2008 Nov; 16(22):9804-16. PubMed ID: 18926711
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, antiviral activity and molecular modeling of oxoquinoline derivatives.
Santos Fda C; Abreu P; Castro HC; Paixão IC; Cirne-Santos CC; Giongo V; Barbosa JE; Simonetti BR; Garrido V; Bou-Habib DC; Silva Dde O; Batalha PN; Temerozo JR; Souza TM; Nogueira CM; Cunha AC; Rodrigues CR; Ferreira VF; de Souza MC
Bioorg Med Chem; 2009 Aug; 17(15):5476-81. PubMed ID: 19581097
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of pyrimidine and quinolone conjugates as a scaffold for dual inhibitors of HIV reverse transcriptase and integrase.
Wang Z; Vince R
Bioorg Med Chem Lett; 2008 Feb; 18(4):1293-6. PubMed ID: 18226894
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of analogues of flazin, in particular, flazinamide, as promising anti-HIV agents.
Tang JG; Wang YH; Wang RR; Dong ZJ; Yang LM; Zheng YT; Liu JK
Chem Biodivers; 2008 Mar; 5(3):447-60. PubMed ID: 18357553
[TBL] [Abstract][Full Text] [Related]
19. 1,2,3-Thiadiazole thioacetanilides as a novel class of potent HIV-1 non-nucleoside reverse transcriptase inhibitors.
Zhan P; Liu X; Cao Y; Wang Y; Pannecouque C; De Clercq E
Bioorg Med Chem Lett; 2008 Oct; 18(20):5368-71. PubMed ID: 18824350
[TBL] [Abstract][Full Text] [Related]
20. 2-(2,6-Dihalo-phenyl)-3-heteroaryl-2-ylmethyl-1, 3-thiazolidin-4-ones: anti-HIV agents.
Rawal RK; Tripathi R; Kulkarni S; Paranjape R; Katti SB; Pannecouque C; De Clercq E
Chem Biol Drug Des; 2008 Aug; 72(2):147-54. PubMed ID: 18624810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
